What is the main difference between Larazotide Acetate and IGF-1 DES?

Larazotide Acetate is primarily classified as a recovery compound (tight-junction regulator developed for celiac disease; reduces intestinal permeability.). IGF-1 DES is a performance compound (truncated igf-1 with localized hypertrophic action; favored for site-specific bodybuilding research.).

Can Larazotide Acetate and IGF-1 DES be stacked together?

Some peptide pairs in different categories (e.g., recovery + cognitive) are commonly stacked. Others overlap mechanistically and shouldn't be combined. Always consult a licensed physician before stacking compounds.

Side-by-side comparison

Larazotide Acetate vs IGF-1 DES

Tight-junction regulator developed for celiac disease; reduces intestinal permeability. versus Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.

Larazotide Acetate

Recovery

Tight-junction regulator developed for celiac disease; reduces intestinal permeability.

Top benefits

✓Tightens intestinal junctions
✓Reduces leaky-gut markers
✓Studied in celiac disease

Full Larazotide Acetate guide→

IGF-1 DES

Performance

Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.

Top benefits

✓Localized muscle hyperplasia
✓Stronger receptor binding than wild-type

Full IGF-1 DES guide→

Attribute	Larazotide Acetate	IGF-1 DES
Category	Recovery	Performance
Type	linear	protein
Chain length	8 aa	67 aa
Formula	C39H56N10O15	modified IGF-1
Common dose	0.5 mg	20–50 mcg
Frequency	3x daily, oral	Post-workout
Top benefit	Tightens intestinal junctions	Localized muscle hyperplasia
Top side-effect	Headache	Hypoglycemia risk

⚠

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.